HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Labeling: FDA "Sensitive" To UPC Code Issues, Agency's Bowen Says

This article was originally published in The Rose Sheet

Executive Summary

FDA is considering omitting the space needed for a properly sized Uniform Product Code symbol from the calculation of whether an OTC package is exempt from the type size requirements of the OTC labeling final rule, FDA ODE V Deputy Director Debra Bowen, MD, and Division of OTC Drugs Director Charles Ganley, MD, said at an OTC labeling "feedback" meeting in Rockville, Md. June 29.

You may also be interested in...



Small Packaging Modifications Allowed In OTC Labeling Reg

FDA is allowing a modified labeling format for product packages too small to conform to the agency's content and format requirements under the OTC drug labeling final rule. The adjustments also apply to unusually shaped packages. The much-anticipated rule was announced by Vice President Gore March 11 and is slated for publication in the Federal Register March 17.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

UsernamePublicRestriction

Register

RS006866

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel